1,196 results on '"Hegenbart, Ute"'
Search Results
2. Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis
3. Patient experiences of interprofessional collaboration and intersectoral communication in rare disease healthcare in Germany – a mixed-methods study
4. Versorgung von Patienten mit kardialer Amyloidose: Konsensuspapier der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK), AG 40 Onkologische Kardiologie, und der Deutschen Gesellschaft für Hämatologie und medizinische Onkologie e. V. (DGHO), der Deutschen Gesellschaft für Neurologie e. V. (DGN) und der Deutschen Gesellschaft für Nephrologie e. V. (DGfN)
5. High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders
6. Leichtkettenamyloidose
7. Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study
8. Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis
9. First third-generation CAR T cell application targeting CD19 for the treatment of systemic IgM AL amyloidosis with underlying marginal zone lymphoma
10. The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018
11. Belantamab Mafodotin-assoziierte Keratopathie – eine häufige und therapiebeeinflussende Nebenwirkung
12. Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy
13. Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study
14. Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial
15. Amyloidose
16. Identification of isoaspartate-modified transthyretin as potential target for selective immunotherapy of transthyretin amyloidosis
17. Prognostic impact of cytogenetic abnormalities by FISH in systemic AL amyloidosis in the era of daratumumab and bortezomib-based frontline combination regimens
18. Proposed hematologic progression criterion in patients with AL amyloidosis.
19. RV-PA uncoupling is a strong predictor of mortality in transthyretin amyloid cardiomyopathy.
20. Fat aspiration for minimally-invasive amyloidosis screening from an external amyloidosis clinic
21. Stem cell collection in AL patients after different induction and mobilization therapies
22. A Platform for Federated Acquisition of Health-related Quality of Life Data in Systemic Amyloidosis
23. Long-term evaluation of amyloidosis diseases in Germany: National Clinical Amyloidosis Registry
24. Biomarker-based renal response and progression criteria in AA amyloidosis: results from the testing cohort of the Pavia-Heidelberg study
25. Patient-reported Diagnostic Journey of Patients Recently Diagnosed with Transthyretin Amyloidosis: Data from the Amyloidosis Research Consortium’s 2022 and 2023 Amyloidosis Community Surveys
26. bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease
27. Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis
28. Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis
29. Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance
30. T2-relaxometry in a large cohort of hereditary transthyretin amyloidosis with polyneuropathy.
31. Response to therapy with tafamidis 61 mg in patients with cardiac transthyretin amyloidosis: real-world experience since approval.
32. HOVON 104, long‐term follow‐up of bortezomib‐dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients.
33. Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group
34. Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series
35. Monoklonale Gammopathie renaler Signifikanz (MGRS)
36. Leichtketten (AL-) Amyloidose
37. Search for AL amyloidosis risk factors using Mendelian randomization
38. Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials
39. Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
40. Impaired in vitro growth response of plasma-treated cardiomyocytes predicts poor outcome in patients with transthyretin amyloidosis
41. Solid state NMR assignments of a human λ-III immunoglobulin light chain amyloid fibril
42. CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma: an intent-to-treat comparison
43. The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysis
44. Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma.
45. Versorgung von Patienten mit kardialer Amyloidose
46. Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients over 60 years of age: a prospective phase II study
47. Idecabtagene Vicleucel Is Well Tolerated and Effective in Relapsed/Refractory Myeloma Patients with Prior Allogeneic Stem Cell Transplantation
48. Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis
49. Role of mutations and post-translational modifications in systemic AL amyloidosis studied by cryo-EM
50. A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.